Notícies de recerca

Joan Montero and colleagues in Boston suggest a new strategy for melanoma patients

IBEC researcher Joan Montero authors a paper in Nature Communications which uncovers a key adaptation that melanoma cancer cells use to evade current therapies. This finding might allow physicians to use better drug combinations to improve patient outcomes in the future.

Despite significant advances in cancer diagnosis and treatment, most targeted cancer therapies fail to achieve complete tumor regressions or durable remission. Understanding why these treatments are not always efficient has remained a main challenge for researchers and physicians. Now, Joan Montero from the IBEC and colleagues at Dana-Farber Cancer Institute/Harvard Medical School in USA report in Nature Communications a mechanism that uncovers why some therapies fail to treat melanoma.

Read more…

Notícies IBEC

El Congrés de la Societat Espanyola d’Enginyeria Biomèdica reuneix més de 200 investigadors sota el lema “Cap a una Salut Personalitzada i Universal”

Raimon Jané, president de la Societat Espanyola d’Enginyeria Biomèdica (SEIB) i Group Leader de l’Institut de Bioenginyeria de Catalunya (IBEC) i del CIBER-BBN (CIBER-BBN), va inaugurar el Congrés junt amb el conseller de Sanitat del Govern de Cantàbria, el rector de la Universitat de Cantàbria, el gerent de l’Hospital i el president del Comitè Organitzador del CASEIB2019.

Read more…